Topic List : Cardiovascular Health
Possible cure for iron-overload disease
Motivated by the loss of a patient, a doctor leads a research effort to uncover the molecular mechanisms of hemochromatosis in the heart.
SHC – ValleyCare rakes in honors
Stanford Health Care – ValleyCare was recognized for overall quality, safety and performance in a number of specialties.
Plant based meat versus animal meat
A diet that includes an average of two servings of plant-based meat alternatives lowers some cardiovascular risk factors compared with a diet that instead includes the same amount of animal meat, Stanford Medicine scientists found.
Unregulated artery cell growth may drive atherosclerosis
Unregulated cell growth seems to be a driver behind the growth of atherosclerotic plaques, changing the traditional story of plaque formation. The rapid cell growth in the arterial wall is similar to pre-cancerous growth in other tissues.
$1.49 million for inflammation research
The Chan Zuckerberg Initiative has awarded $1.49 million to research projects involving Stanford Medicine scientists who will investigate emerging ideas about the role of inflammation in disease.
Grant to study digital heart-health tools
The award will fund a research program for heart-health technology and a clinical trial for treating hypertension in black and Hispanic participants and in drivers for ride-hailing companies.
AHA chief on research, health equity and more
Robert Harrington, the new president of the American Heart Association, recently discussed his views on technology and diversity in medicine.
Transitional services after heart failure worth cost
A new study asserts that disease-management clinics, home visits by nurses and nurse case management should become the standard of care for elderly patients with heart failure after they are discharged from the hospital.
Nanotherapy reduces artery plaque in mice
Stanford researchers have found that drug-coated nanoparticles limit the development of atherosclerosis in mice, without side effects.
Minimally invasive valve replacement
A recent decision by the Food and Drug Administration opened the door for Sharon Kramer of Atherton, California, to undergo a less-invasive heart valve replacement.